This CEO is trying to genetically modify pig organs for human transplant and turn more Sci-Fi ideas into common cures

United Therapeutics CEO Martine Rothblatt is a trailblazer in drug development for rare diseases. She is now developing technology to tackle the organ shortage in America.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.